Tag: Business

Good day, and thank you for allowing me to share some interesting insights with you. I'm still active on the platform previously known as Twitter, which shows that old habits die hard. It seems...

Biotech analyst Brian Skorney and biotech executive Daphne Zohar recently appeared on "The Readout LOUD" podcast to share their thoughts on how the outcomes of the recent election may impact the biotech industry. They...

Novartis made a significant move in the field of gene therapy by acquiring Kate Therapeutics for up to $1.1 billion. This acquisition includes not only the gene therapy startup itself but also its drug...

As we approach the end of another workweek, it's time to start thinking about weekend plans. Our schedule includes tending to the Pharmalot grounds, spending time with our beloved mascots, and catching up on...

Highlights from J.P. Morgan Healthcare Conference Day 2The J.P. Morgan Healthcare Conference on Day 2 saw a flurry of activity, with key industry figures making headlines and sharing insights that could shape the future...

Unveiling JPM Day 1: A Comprehensive Overview for InvestorsWelcome to STAT’s exclusive coverage of the much-anticipated “JPM Week” in San Francisco, where the biotech world is abuzz with groundbreaking news, insightful analysis, and juicy...

MAPLE GROVE, Minn. - On a fateful day in New York City, the world lost Brian Thompson, the esteemed CEO of UnitedHealthcare. Thompson's journey from a small town in Iowa to the pinnacle of...

Good day, everyone! We hope you are all well despite the rainy weather. Remember, each day is a gift waiting to be unwrapped. As we take a short break for the upcoming holiday, let's...

Recursion Pharmaceuticals, a company known for its innovative use of artificial intelligence and machine learning in drug development, recently made the decision to lay off employees following a merger with Exscientia. This move comes...

Good morning, everyone! Today, we have some interesting updates from the biotech industry. The BIOSECURE Act is facing a crucial moment as it needs to be passed by Congress by December to avoid obstacles,...

Pfizer has welcomed a new R&D head, Chris Boshoff, who is expected to make significant strides in research and development to satisfy investors. Additionally, the biotech venture capital landscape is set to see some...

Intentional Genomic Alterations (IGAs) in animals refer to changes made to an animal's DNA using modern molecular technologies. These alterations can include targeted DNA sequence changes like insertions, substitutions, or deletions, among others. Common...